^SAMPLE = GSM559637!Sample_title = Array CGH data for breast cancer cell line T47D!Sample_geo_accession = GSM559637!Sample_status = Public on Jun 25 2010!Sample_submission_date = Jun 24 2010!Sample_last_update_date = Jun 29 2010!Sample_type = genomic!Sample_channel_count = 2!Sample_source_name_ch1 = normal female reference DNA!Sample_organism_ch1 = Homo sapiens!Sample_taxid_ch1 = 9606!Sample_characteristics_ch1 = reference: Normal female reference genomic DNA (Promega)!Sample_molecule_ch1 = genomic DNA!Sample_extract_protocol_ch1 = Genomic DNA was extracted from untreated cells using the NucleoSpin Tissue kit with the protocol for cultured cells.										!Sample_label_ch1 = Cy3!Sample_label_protocol_ch1 = Six micrograms of digested and purified DNA was labelled with Cy3-dUTP in a random priming reaction using BioPrime DNA Labelling System.										!Sample_source_name_ch2 = breast cancer cell line T47D!Sample_organism_ch2 = Homo sapiens!Sample_taxid_ch2 = 9606!Sample_characteristics_ch2 = cell type: breast cancer cell line!Sample_characteristics_ch2 = cell line: T47D!Sample_growth_protocol_ch2 = Cell cultures were grown to 70-80% confluence in 175 cm2 flasks according to distributor's instructions (ATCC).										!Sample_molecule_ch2 = genomic DNA!Sample_extract_protocol_ch2 = Genomic DNA was extracted from untreated cells using the NucleoSpin Tissue kit with the protocol for cultured cells.										!Sample_label_ch2 = Cy5!Sample_label_protocol_ch2 = Six micrograms of digested and purified DNA was labelled with Cy5-dUTP in a random priming reaction using BioPrime DNA Labelling System.										!Sample_hyb_protocol = Labelled tumor and reference samples were combined and hybridized onto the arrays according to the direct method of the June 2006, version 4 protocol (Agilent Technologies, Palo Alto, CA). After hybridization, arrays were washed according to manufacturer's instructions.!Sample_scan_protocol = Arrays were scanned using the G2505B scanner from Agilent Technologies. Signal intensities were quantified using the Feature Extraction software from Agilent.!Sample_description = A hybridization of untreated T47D human breast cancer cells compared to normal human female genomic DNA.!Sample_data_processing = Agilent Feature Extraction Software version 9.1.1.1 was used for spot quality filtering and normalization using default settings.!Sample_platform_id = GPL4091!Sample_contact_name = Henrik,,Edgren!Sample_contact_email = henrik.edgren@helsinki.fi!Sample_contact_institute = Institute for Molecular Medicine, University of Helsinki!Sample_contact_address = Tukholmankatu 8!Sample_contact_city = Helsinki!Sample_contact_zip/postal_code = 00290!Sample_contact_country = Finland!Sample_supplementary_file = ftp://ftp.ncbi.nlm.nih.gov/geo/samples/GSM559nnn/GSM559637/suppl/GSM559637.txt.gz!Sample_series_id = GSE22547!Sample_data_row_count = 243430#ID_REF = #VALUE = processed log10 ratio Cy5/Cy3 (T47D/ref)!sample_table_beginID_REF	VALUE1	1.710630047e-0022	0.000000000e+0003	0.000000000e+0004	-2.353167996e-0025	1.727449348e-0016	-1.821044883e-0017	2.388549465e-0018	-5.076185552e-0029	2.812087600e-00110	-2.412010827e-00111	3.888118109e-00112	1.483568264e-00113	-1.415926299e-00114	-2.902707069e-00215	3.302267682e-00116	-1.918786274e-00117	1.455670324e-00118	3.605860970e-00219	1.963891955e-00420	1.263809473e-001!sample_table_end